Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Concerta
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Concerta XL 36mg tablets
0404000M0BDABAN
|
Concerta | Methylphenidate hydrochloride | Central Nervous System | 20,715 |
|
Concerta XL 27mg tablets
0404000M0BDAEAT
|
Concerta | Methylphenidate hydrochloride | Central Nervous System | 17,243 |
|
Concerta XL 54mg tablets
0404000M0BDAFAR
|
Concerta | Methylphenidate hydrochloride | Central Nervous System | 16,032 |
|
Concerta XL 18mg tablets
0404000M0BDAAAM
|
Concerta | Methylphenidate hydrochloride | Central Nervous System | 14,892 |
|
Concerta 27mg modified-release tablets
0404000M0BDADAT
|
Concerta | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Concerta 54mg modified-release tablets
0404000M0BDACAR
|
Concerta | Methylphenidate hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.